Aim: To examine the time-and dose-dependent effects of ouabain on human umbilical vein endothelial cells (HUVEC) in vivo, and the changes in aortic endothelium and the different expression levels of Kv4.2 in vitro. Methods: The proliferation of HUVEC and cell death were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay, the incorporation of [ 3 H]TdR, trypan blue staining, and lactate dehydrogenase (LDH) release. The response of endothelial cells to ouabain was explored with a complementary DNA microarray and a candidate gene was found. "Ouabain-sensitive" hypertensive rats were established by chronic administration of ouabain. Changes in the aortic endothelium were observed by electron microscopy, and the expression level of Kv4.2 in different animals was studied by using real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR). Results: Ouabain stimulated the proliferation of HUVEC at physiological concentrations (0.3−0.9 nmol/L). Ouabain at pathological concentrations (0.9−1.8 nmol/L) inhibited proliferation and induced cell death. mRNA profile analysis indicated that 340 genes were differentially expressed after ouabain treatment: 145 were upregulated, of which 6 were upregulated significantly, including KCND2 (encoding the potassium voltagegated channel shal-related subfamily member 2). The upregulated genes were mainly related to cell metabolism and transcription. In ouabain-sensitive hypertensive rats, the aortic endothelium was damaged and Kv4.2 (coded by KCND2) was over-expressed. Conclusion: The physiological role of ouabain in HUVEC might involve the control of growth and metabolism. Ouabain at pathological concentrations might affect the structure and function of the vascular endothelium by modification of expression of the KCND2 gene, and participate vascular remodeling in hypertension.
Introduction
Ouabain and other cardiac glycosides have been known as specific inhibitors of sodium pumps and purified Na + /K + -ATPases ever since the very first observations of inhibition of the sodium pumps of red blood cells. As an endogenous mammalian counterpart to cardiac glycosides and an inhibitor of sodium pumps, it regulates the body fluid volume balance, in addition to urine sodium extraction and vasoconstrictive tone, thus playing an important role in the pathogenesis of hypertension and some other cardiovascular disorders [1] . Although ouabain is known to induce hypertension, the mechanism by which this cardiac glycoside affects blood pressure and vascular remodeling is uncertain. In 1976, Ross proposed that chronic hypertension might induce endothelium damage, and result in vascular remodeling and target organ dysfunction, and since then the role of endothelium in cardiovascular diseases has been confirmed. The physiological and pathophysiological importance of ouabain in the vascular endothelium is not clear. The objective of the present study was to investigate: (i) the effect of ouabain at different concentrations on human umbilical vascular endothelial cells (HUVEC); (ii) the mechanism by which ouabain exerts its effect; and (iii) its potential role in hypertensive vascular remodeling.
Materials and methods

Cell cultures
Ouabain was from Sigma (St Louis, MO, USA). HUVEC were cultured in RPMI-1640 medium (Gibco, Logan, Utah, USA) supplemented with 15% heat-inactivated fetal calf serum (FCS), endothelial cell growth factor 3 mg/mL, penicillin 200 U/mL, streptomycin 100 mg/mL, and L-glutamine 20 mmol/L, and incubated in a humidified atmosphere with 5% CO 2 at 37 o C. At passage 2-3, the confluent HUVEC were used for experiments. HUVEC were added to a 96-well multiplate with 5×10 3 cells in each well, and incubated with RPMI-1640 medium without FCS to preserve quiescence. Twentyfour hours later the medium was changed with RPMI-1640 medium supplemented with FCS.
Cell morphology analysis Cell morphology was evaluated by phase-contrast microscopy without preliminary fixation. To estimate cell attachment, cells growing in 6-well plates in the absence or presence of ouabain were washed 4 times with phosphate-buffered saline. Next, the cells were harvested with 0.05% trypsin. After fixation, dehydration, embedding, and sectioning using routine methods, the cells were observed with a Hitachi H600 transmission electron microscope (Hitachi, Tokyo, Japan).
Cell viability measurement Cell viability was measured by using a colorimetric assay with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT). Briefly, the cells were incubated with ouabain at different concentration (0.3, 0.6, 0.9, 1.2, 1.8, 10, 100, 1000 nmol/L) and for different durations (0.5, 1, 2, 4, 8, 16, 24, 48 h), respectively. Then the 0.5 mg/mL MTT solution (Sigma) was added to each well and the cells were incubated for a further 4 h at 37 o C. After the cells were washed 3 times with phosphate-buffered saline (PBS; pH 7.4), the insoluble formazon product was dissolved by incubation with 150 µL Me 2 SO for 15 min. The absorbance (A) of each well was measured on an enzymelinked immunosorbent assay (ELISA) micro-plate reader at 490 nm. The cells without ouabain treatment served as controls. Each experiment was performed in quadruplicate. The proliferation rate was calculated as follows: (A Exp /A Control -1) ×100%.
Trypan blue exclusion assay HUVEC were incubated in the absence or presence of ouabain 0.3 or 1.8 nmol/L for 8 h. Both attached and floating cells were combined and stained with 0.2% trypan blue. Viable cells were counted and expressed as a proportion of cells without ouabain treatment.
Lactate dehydrogenase assay HUVEC were incubated in RPMI-1640 supplemented with FCS containing ouabain 0.3 or 1.8 nmol/L for 8 h. A 0.5 mL aliquot of supernatant was transferred to the same volume of 1% Triton X-100, and attached cells were lysed with 500 µL 0.5% Triton X-100 at room temperature for 15 min. Subsequently, aliquots (300 µL supernatant or lysate) were transferred into 2 mL buffer containing Tris-HCl 50 mmol/L (pH 7.4), KCl 50 mmol/L, reduced β-nicotinamide-adenine dinucleotide (NADH) 0.075 mmol/L, and sodium pyruvate 1 mmol/L. The kinetics of NADH degradation were monitored with a SPEX FluoroMax spectrofluorimeter (Edison, NJ, USA) at λ ex =349 nm and λ em =420 nm (slits 4 and 20 nm, respectively). The total cellular lactate dehydrogenase (LDH) activity was determined from the activity of the lysate plus the activity of the supernatant. The percentage of LDH released was expressed as the proportion of LDH released into medium as compared with the total amount of LDH. Gene chip detection The BiostarH-80s gene chip with 8464 spots was used (Shanghai Biostar Genechip, Shanghai, China). After incubation with ouabain 0.3 nmol/L for 2 h, total RNA of the endothelial cells was extracted according to the original single-step extraction procedure of Chomczynski et al [2] . Messenger RNAs were purified by using an Oligotex dT mRNA Midi kit (Qiagen, Carlsbad, CA, USA). The fluorescent cDNA probes were prepared by reverse transcription of the isolated mRNA and then purified according to the method of Schena et al [3] . The RNA samples from the ouabain-free group were labeled with Cy3-dUTPs and those from the ouabain group with Cy5-dUTPs. The two colored probes were then mixed, precipitated with ethanol and dissolved in 20 µL of hybridization solution [5×SSC (0.75 mol/L NaCl and sodium citrate 0.075 mol/L), 0.4% sodium dodecylsulfate (SDS), 50% formamide, and 5×Denhardt's solution (0.1% Ficoll, 0.1% polyvinylpyrrolidone, and 0.1% bovine serum albumin)]. Microarrays were pre-hybridized with hybridization solution containing denatured salmon sperm DNA 0.5 mg/mL at 42 o C for 6 h. Fluorescent probe mixtures were applied onto the pre-hybridized chip under cover glass.
Chips were hybridized at 42 o C for 15−17 h. The hybridized chips were then washed at 60 o C for 10 min in solutions of (i) 2×SSC and 0.2% SDS; (ii) 0.1×SSC and 0.2% SDS; and (iii) 0.1×SSC, respectively, then dried at room temperature. The chips were scanned with a ScanArray 4000 (Packard BioScience, Billerica, MA, USA) at two wavelengths to detect emissions from both Cy3 and Cy5. The acquired images were analyzed using ImaGene 3.0 software (BioDiscovery, Inc, Los Angeles, CA). The intensities of each spot at the two wavelengths represented the quantities of Cy3-dUTP and Cy5-dUTP, respectively, hybridized to each spot. Ratios of Cy5 to Cy3 were computed for each location on each microarray.
Established animal model The rats used to establish the animal model were grade II, and the certificate number of the breeder is 08-005. The project was approved by the Animal Experimentation Ethics Committee of Xi'an Jiaotong University. Six-to-ten-week-old male Sprague-Dawley rats (150−200 g) were used for the experiments after being kept in a temperature-controlled room for a week. The rats were randomly assigned to the experimental and control groups. The rats in the former group (n=52) received a maintenance dose of ouabain intraperitoneally. On d 1, a loading dose of 34 µg/kg ip was administered, followed by a dose of 27.8 µg·kg -1 ·d -1 ip for an additional 8 weeks every day. The control group (n=20) received vehicle (0.9% saline) only. Ouabain was dissolved in sterile saline at a concentration of 20 µg/mL and stored for up to 1 week at 4 o C in the dark [4] . Systolic blood pressure was recorded with a tail cuff once a week using a heart rate and blood pressure recorder for rats (RBP-1B; China-Japan Clinical Medicine Institute, Beijing, China). The average of 3 recordings was taken as the individual systolic blood pressure. Measurements obtained using this method correlate well with those obtained using the direct cannulation method [5] . The 2 groups of animals were kept in the same conditions during the experiment and all were killed after 8 weeks. At that time, tissue samples were collected for experiments.
Electron microscopy Animals were anesthetized with 20% urethane ip, and the ascending aorta was then removed. Samples of the aorta were chipped into 1 mm×1 mm×1 mm blocks, and pre-fixed in the glutaraldehyde buffer for 2 h. After dehydration, embedding, and sectioning using routine methods, the sections were observed with a Hitachi H600 transmission electron microscope. The remaining part of the aorta was preserved in liquid nitrogen for reverse transcription-polymerase chain reaction (RT-PCR).
RT-PCR primers and probe design Primers and probes for quantitative RT-PCR were designed and synthesized by the Shanghai Sangon Biological Engineering Technology and Service Co (Shanghai, China). The melting temperature for primers was set at 50−60 o C, but the probe's melting temperature was at least 10 o C higher. The minimum GC content for the primers and probes was 20%−80%, and runs of identical nucleotides were avoided. The strands were between 9 and 40 nucleotides in length.
Quantitative RT-PCR Total RNA was extracted using the Trizol Max kit (Invitrogen, Carlsberg, CA, USA). Fluorescent real-time quantitative RT-PCR was used to determine differences between the model group and control group with respect to Kv4.2 mRNA expression levels in the endothelium of the ascending aorta. Expression levels were quantitated using a one-step RT-PCR reaction using the Super Script One-Step RT-PCR kit with Platinum Tag (Invitrogen), following the manufacturer's instructions (with modifications). A total reaction volume consisted of 1 µL forward primer, 1 µL reverse primer, 1 µL fluorescent probe, 1 µL RT/Platinum Taq Mix and 4 µL total RNA was made up to 50 µL with RNasefree water. One-step RT-PCR amplification was performed in the ABI Prism 7700 Sequence Detection System (Perkin-Elmer, Foster City, CA). Thermal cycling conditions were as follows: 94 °C for Statistical analysis Data are expressed as mean±SEM. Difference between groups before and after treatment were tested by using the paired t-test, and comparisons between groups were carried out using Student's t-test. P<0.05 was considered significant.
Results
Effect of ouabain on morphology of HUVEC After HUVEC were treated with ouabain 0.3 nmol/L for 8 h, the morphology of HUVEC was similar to that of the control group. But ouabain 1.8 nmol/L induced apoptosis in endothelial cells. Cell swelling and apoptotic bodies were observed (Figure 1) .
Effect of ouabain on the proliferation of HUVEC Treatment with ouabain at 0.3−0.9 nmol/L for 2 h stimulated cell proliferation ( Figure 2 ). However, ouabain at a concentration of 1.8 nmol/L for 0.5 h induced some cell proliferation ( Figure 3B) , and then showed an anti-proliferative effect after long-term treatment. In contrast, compared with the control group, cell proliferation increased by 50% after treatment with ouabain at a concentration of 10 nmol/L. With an increase of the concentration of ouabain (100, 1000 nmol/L), the proliferation rate gradually decreased (Figure 2 Effect of ouabain on the gene expression profile Scatter plots and two-color fluorescence after hybridization indicated that 340 genes were expressed differently in response to ouabain treatment. One hundred and forty-five genes were upregulated, among which 6 genes were markedly upregulated, including KCND2 gene. The upregulated genes were mainly related to cell metabolism and transcription (Table  2) . We focused on the KCND2 gene and carried out a further experiment in relation to it.
Effects of continued infusion of ouabain on systolic blood pressure In the first 4 weeks the SBP of all rats increased, accompanied by an increase in weight; however, there was no significant difference between the ouabain group and the control group. From the fifth week, the SBP of 45 of the 52 rats in the ouabain group began to increase. Six weeks later the SBP of the 45 rats were markedly higher than those of the control group, which received normal saline (142.3±8.2 mmHg vs 123.4±5.4 mmHg; P<0.01]. These 45 rats were designated "ouabain-sensitive" (OS) rats. In the remaining 7 rats in the ouabain group, the SBP did not increase, and these 7 rats were designated "ouabain-resistant" (OR) rats ( Figure 5 ). 
Changes in aortic endothelium in OS and OR rats
In OS rats, the structure of the aortic endothelium was damaged and the nuclei were depleted. In OR rats, the aortic endothelium was integrated, the nuclei were clear, and the endothelial cells were tightly linked to the internal elastic membrane ( Figure 6 ).
Effect of ouabain on Kv4.2 gene expression in OS and OR rats Kv4.2 expression was markedly higher in OS rats than in OR and control rats (P<0.01; Figure 7 ).
Discussion
Ouabain is one of the most highly hydroxylated, water soluble and potent cardiac glycosides. It was recognized as the primary active component of Masai arrow poison more than 100 years ago by the French anthropologist Arnaud. Recent work has shown that ouabain (or closely related isomers) is present in the human circulation [6] . The effect of ouabain as a sodium pump (Na [7] . The effect of ouabain on cell survival is tissue-specific [8] . Twentyfour hours of treatment with ouabain detaches and kills Ouabain has been known to act as a hormone and is possibly involved in the pathogenesis of hypertension [9] . To investigate the mechanism that is involved in the vascular remodeling that occurs during hypertension, we studied the effects of ouabain on HUVEC in culture. We found that ouabain at physiological concentrations (0.3−0.9 nmol/L) stimulated the proliferation of HUVEC. However, at pathological concentrations (0.9−1.8 nmol/L), cell death was induced, including the swelling phenomenon and appearance of apoptosis bodies. As Xiao et al suggested, the neuronal death associated with ouabain treatment consisted of concurrent apoptotic and necrotic components [10] . The proteome analysis indicated that ouabain treatment led to overexpression of numerous soluble and hydrophobic cellular proteins [11] . The results of mRNA profile analysis indicated that most of the upregulated genes were related to signal transduction and metabolism. The candidate genes were screened from the abovementioned genes and analyzed further.
We found that the protein kinase gene (NM_002737) an d pr otein ph osph atase genes (NM_014225 an d NM_002719) were upregulated. These 2 genes regulate signal transduction by catalysis phosphorylation and dephosphorylation. The protein kinase and protein phosphatase act on tyrosine, serine, and threonine, related to cell proliferation and differentiation [12, 13] . DAPK1 (death-associated protein) (NM_004938), a calcium/calmodulin-dependent serine/threonine kinase, exerts apoptotic effects by suppressing integrin functions and integrin-mediated survival signals, and activating a p53-dependent apoptotic pathway [14] . According to these early responsive gene (ERG), ouabain mediates the expression of downstream genes, and makes the endothelial cells in normal metabolism condition. Also, ouabain upregulates many transcription genes, such as tumor necrosis factor receptor-associated factor family member-associated NF-κB activator (TANK) (NM_004180), E2F 4 (NM_001950), GTF21(NM_0999), CREBBP (NM_004380) and TFIIF (NM_002096). NF-κB, which is activated by ouabain and TANK, plays a role in immunity protection, anti-inflammation, vasomotion and cell proliferation by regulating some cytokine genes and triggering endothelial cells to secrete cytokines [15, 16] . The results of the present study implied that NF-κB was activated. The arrestin beta 1 gene (NM_004041) was upregulated in the mRNA profiles analysis. Members of the arrestin/beta-arrestin protein family are thought to participate in agonist-mediated desensitization of G-protein-coupled receptors and cause specific dampening of cellular responses to stimuli, such as hormones, neurotransmitters, or sensory signals. Arrestin beta 1 is a cytosolic protein that acts as a cofactor in the beta-adrenergic receptor kinase-mediated desensitization of beta-adrenergic receptors [17] . Physiological ouabain might be a beta-adrenergic receptor inhibitor according to upregulation of the arrestin beta 1 gene, which was proved by the downregulation (Cy5/Cy3=0.374) of the beta 2-adrenergic receptor kinase (ADRBK2) found in the present study.
KCND2, which was found to be upregulated in the present study, is related to the potassium current, and ouabain is an inhibitor of sodium pumps. Therefore, in the present paper, we only focused on KCND2. Voltage-gated potassium (Kv) channels, which induce outward K + ion currents, are the most complex class of voltage-gated ion channels with respect to both functional and structural aspects [16] . They consist of 4 sequence-related potassium channel proteins: shaker, shaw, shab and shal, which are encoded by KCNA, KCNB, KCNC and KCND, respectively. Their diverse functions include regulation of neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume [18] . Kv4.2/Kv4.3, which are related to the shal subfamily encoded by KCND, participate in the formation of transient outward K + ion current (I to ), are expressed in the epicardium of the atrium and ventricles, and create the action potential repolarization I phase.
Kv channels control action potential repolarization, membrane potential, and action potential frequency in excitable cells. The gene chip findings of the present study showed that KCND was upregulated HUVEC after treatment with ouabain. The SBP of OS rats treated with ouabain increased, the aortic endothelium became structurally damaged, and the expression level of Kv4.2 was higher than that of the control group [19] . The pressure, the structure of the aortic endothelium, and the Kv4.2 expression level did not change in OR rats compared with the control group. The findings indicated that endothelial cells had Kv4.2 channels encoded by KCND2, which is involved in the cell functions related to regulating ion transport in the cells. Expression of the Kv4.2 channel was upregulated after chronic treatment with ouabain, which might induce changes in the potassium concentration inside and outside cells, and then indirectly inhibit the sodium pump of the membrane. The relationship between Kv4.2 expression, pressure increases and endothelium damage indicate that Kv channels might be a prominent factor in the pathological process whereby ouabain induces hypertension vascular remodeling.
The results of the present study suggest that ouabain might be involved in controlling the growth and metabolism of vascular endothelium cells at physiological concentrations, but at pathological concentrations it might affect the structure and function of endothelial cells, and trigger vascular remodeling in hypertension. Nonetheless, some questions require further study, for example why ouabain was able to stimulate proliferation at a concentration of 10 nmol/L, which is higher than that found under pathological conditions? Is there "autocrine" and "paracrine" ouabain in endothelial cells, such as occurs for other hormones (eg, rennin)? We will address these questions in future studies.
